Excessive false-positive errors in single-arm phase II trials: A simulation-based analysis

被引：0
|
作者：
Tang, H. [1 ]
Foster, N. R. [1 ]
Grothey, A. [1 ]
Ansell, S. M. [1 ]
Sargent, D. J. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6512
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Bayesian predictive probability design in single-arm cancer phase II trials: is it superior to frequentist design?
    Liu, Xinxue
    Cornelius, Victoria R.
    TRIALS, 2017, 18
  • [22] Stata command for calculating adverse event and efficacy stopping boundaries for phase II single-arm trials
    Fellman, Bryan M.
    STATA JOURNAL, 2014, 14 (02): : 407 - 417
  • [23] Adaptive sequential design for phase II single-arm oncology trials: an expansion of Simon's design
    Gao, Ping
    Zhang, Weidong
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024,
  • [24] Single-Arm Phase II Trials of Combination Therapies: A Review of the CTEP Experience 2008-2017
    Foster, Jared C.
    Freidlin, Boris
    Kunos, Charles A.
    Korn, Edward L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (02): : 128 - 135
  • [25] Historical Controls for Metastatic Pancreatic Cancer: Benchmarks for Planning and Analyzing Single-Arm Phase II Trials
    Philip, Philip A.
    Chansky, Kari
    LeBlanc, Michael
    Rubinstein, Lawrence
    Seymour, Lesley
    Ivy, S. Percy
    Alberts, Steven R.
    Catalano, Paul J.
    Crowley, John
    CLINICAL CANCER RESEARCH, 2014, 20 (16) : 4176 - 4185
  • [26] Analysis of phase II methodologies for single-arm clinical trials with multiple endpoints in rare cancers: An example in Ewing's sarcoma
    Dutton, P.
    Love, S. B.
    Billingham, L.
    Hassan, A. B.
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2018, 27 (05) : 1451 - 1463
  • [27] Simulation-Based Training of the Rapid Evaluation and Management of Acute Stroke (STREAM)-A Prospective Single-Arm Multicenter Trial
    Bohmann, Ferdinand O.
    Kurka, Natalia
    de Rochemont, Richard du Mesnil
    Gruber, Katharina
    Guenther, Joachim
    Rostek, Peter
    Rai, Heike
    Zickler, Philipp
    Ertl, Michael
    Berlis, Ansgar
    Poli, Sven
    Mengel, Annerose
    Ringleb, Peter
    Nagel, Simon
    Pfaff, Johannes
    Wollenweber, Frank A.
    Kellert, Lars
    Herzberg, Moriz
    Koehler, Luzie
    Haeusler, Karl Georg
    Alegiani, Anna
    Schubert, Charlotte
    Brekenfeld, Caspar
    Doppler, Christopher E. J.
    Onur, Oezguer A.
    Kabbasch, Christoph
    Manser, Tanja
    Pfeilschifter, Waltraud
    Alotaibi, Mohammad
    Batarfi, AbdulAziz
    Brandhofe, Annemarie
    Kestner, Roxane-Isabelle
    Schaefer, Jan Hendrik
    Schaller, Martin Alexander
    Seiler, Alexander
    Wallenwein, Stephanie
    Willems, Laurent M.
    Steinmetz, Helmuth
    Hattingen, Elke
    Kos, Zeljko
    Naumann, Markus
    Blum, Corinna
    Bombach, Paula
    Zeller, Julia
    Gumbinger, Christoph
    Regula, Jens
    Horstmann, Solveig
    Heyse, Miriam
    Dorozewski, Eva
    Lamentner, Christian, I
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [28] Optimal Two-stage Designs for Single-arm Phase II Oncology Trials with Two Binary Endpoints
    Kunz, C. U.
    Kieser, M.
    METHODS OF INFORMATION IN MEDICINE, 2011, 50 (04) : 372 - 377
  • [29] A new design for phase II single-arm clinical trials: Bayesian predictive sample size selection design
    Teramukai, Satoshi
    Daimon, Takashi
    Zohar, Sarah
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Using historical objective response rates to design single-arm phase II trials in patients with recurrent glioblastoma
    Grossman, Stuart A.
    NEURO-ONCOLOGY, 2023, 25 (06) : 1029 - 1030
12345